Researchers at the National Institutes of Health's National Center for Advancing Translational Sciences (NCATS), Clinical Center and National Institute of Allergy and Infectious Diseases (NIAID) have created a new way to ...
Nov 10, 2016
0
0
In treating diseases with drugs, dosing is critical; too little is ineffective, while too much can be lethal. Colorado State University's Brad Reisfeld takes a mathematical approach to achieving optimal dosing for various ...
Jun 8, 2016
0
0
France's health minister presented a plan on Monday to tighten the rules regarding human drug trials following an experimental test that killed a volunteer in January.
May 23, 2016
0
0
Turkmenistan has passed a law making HIV tests mandatory prior to marriage, state media reported on Wednesday, in a sign the reclusive Central Asian state fears the spread of a disease it has always downplayed.
Apr 6, 2016
0
3
US health authorities issued guidelines Tuesday to limit prescribing opioid painkillers, in an attempt to help curb an epidemic of overdoses that kills more than 40 Americans every day.
Mar 16, 2016
0
3
Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle "superbugs"—infections that increasingly don't respond to drugs and threaten millions of people in countries rich ...
Jan 21, 2016
0
56
A new test for club drugs like ketamine can detect low levels of drugs in urine and plasma, making it faster, easier and cheaper to identify them. The authors of the study, published in Journal of Chromatography B, say it ...
Nov 25, 2015
0
2
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Nov 4, 2015
0
1498
It's a wonder of modern science that, for at least some types of cancer, doctors are now able to exploit the unique genetic faults in a person's tumour to treat their disease with precision drugs.
Aug 20, 2015
0
4
Infectious diseases researchers from the University of Pittsburgh School of Medicine are leading a five-year, $5 million initiative to monitor drug resistance during the rollout of HIV prevention drugs in sub-Saharan Africa.
Aug 3, 2015
0
22
